What does non-invasive cardiac function testing check?

Monthly prenatal check-ups during pregnancy are very important. Doctors can only judge the growth and development of the fetus based on the prenatal check-up items and data, and can also check the physical condition of the pregnant woman. If any abnormalities are found, effective measures will be taken to minimize the abnormal data. So what does minimally invasive cardiac function test check?

The vaccine can be used in the production of DNA vaccines in the following groups: 1. Older pregnant women (age ≥ 35 years old) who are willing to choose prenatal examination; 2. Pregnant women with high risk of Down syndrome screening or changes in single project indicators who are willing to choose prenatal examination; 3. Pregnant women with increased fetal NT value or anatomical abnormalities in B-ultrasound during pregnancy who are willing to choose prenatal examination; 4. Pregnant women who are carriers, have placenta previa, low-lying placenta, oligohydramnios, negative RH blood type, history of miscarriage, threatened abortion or pregnancy who are suitable for prenatal examination; 5. Pregnant women who want to undergo or can undergo prenatal examination again if cell culture of amniocentesis is unsuccessful; pregnant women who hope to eliminate fetal trisomy 21, trisomy 18, and trisomy 13 syndrome and agree to choose prenatal examination; 6. Pregnant women with positive blood cell screening and pregnant women with medical obstacles for prenatal examination.

Therefore, if pregnant women over 35 years old are determined to undergo minimally invasive surgery, they can also consider minimally invasive screening after sufficient communication with the doctor. In addition, pregnant women who conceived through in vitro fertilization and pregnant women with twins also belong to the group that should use minimally invasive DNA prenatal diagnosis with caution.

Minimally invasive DNA testing can be done around 16-20 weeks of pregnancy to determine the baby's IQ.

There are various ways to test for chromosomal abnormalities in the growing fetus, including minimally invasive DNA prenatal testing, also known as minimally invasive prenatal DNA testing, minimally invasive fetal sex chromosome aneuploidy testing, etc. According to the American Association of Colleges of Obstetricians and Gynaecologists, an international authoritative academic research organization, minimally invasive prenatal DNA testing (Non-invasive Prenatal Testing) is the name of the most widely used technology.